Chondroitin sulfate (CS) is present in connective tissues. It consists of repeating (1!4)-linked disaccharide units of -D-glucuronic acid linked (1!3) to Nacetyl--D-galactosamine. The two most common isomers, chondroitin sulfate A (CS-A) and chondroitin sulfate C (CS-C), are sulfated at C-4 and C-6 respectively of the galactosamine residue. 1) CS is usually found as a component of proteoglycans, bound with proteins.
CS-A and -C are derived from such bovine tissues as the trachea and shark cartilage respectively. Several reports have indicated that CS has anti-inflammatory characteristics. [2] [3] [4] [5] It is therefore commonly used as an ingredient for dietary supplements taken as alternative medicines, to treat osteoarthritis. CS has also been approved and regulated as a symptomatic slow-acting drug for this disease (SYSADOA) in European, and some other countries.
6) It might also be of interest for the treatment of other diseases with an inflammatory and/or autoimmune character, such as inflammatory bowel disease (IBD), degenerative diseases of the central nervous system, and stroke, multiple sclerosis, and other auto-immune diseases. 7) Although intestinal absorption of CS is controversial, 6, 8) a variety of analytical methods, including pharmacokinetic studies performed on humans, have indicated that it can be absorbed by the oral route. 3, [9] [10] [11] [12] [13] [14] Small CSs, including CS-oligosaccharides (oligoCSs) and CS-disaccharides (Di-CS), were recently focused to play critical roles in immune-modulating functions. A synthesized CS tetrasaccharide has been reported to stimulate the growth and differentiation of neurons.
15) It has also been reported that Di-CSs protected nerve cells from inflammation-associated neurodegeneration 16, 17) and retinal cells from elevated intraocular pressure in aged and immunocompromised rats. 18) Since several in vivo 11, 13, 14, 19) and in vitro 19, 20) studies have suggested that low molecular weight CSs can be absorbed more easily than larger-molecular CSs.
Orally-fed oligo-CSs possibly modulate the functions of immune cells beneath the intestinal epithelial cell monolayers. Macrophages, the predominant immune cells, acting in non-specific innate immunity as well as helping to initiate specific adaptive immunity in vertebrate animals, express a large repertoire of classes of pattern-recognition receptors, including mannose receptors, scavenger receptors, and toll-like receptors (TLRs). [21] [22] [23] In response to pathogens, activation of the innate immune system through the TLRs on macrophages results in the production of pro-inflammatory cytokines, including tumor necrosis factor (TNF)-and interleukin (IL)-6. 24, 25) Macrophages play important roles in the initiation, propagation, and resolution of inflammation, and in inflammation-related pathogenesis such as IBD, 26) cancer, 27) and rheumatoid arthritis (RA). 28, 29) Numerous studies have demonstrated that arthritis can develop after infection by bacteria. [30] [31] [32] [33] Furthermore, the activation of macrophages in arthritis by bacterial/ y To whom correspondence should be addressed. Tel: +81-3-5841-5127; Fax: +81-3-5841-8026; E-mail: ams316@mail.ecc.u-tokyo.ac.jp Abbreviations: CpG, unmethylated CpG motifs present in bacterial and viral DNA; CS, chondroitin sulfate; Di-CS, disaccharides derived from CS; IL, interleukin; oligo-CS, oligosaccharides derived from CS; TLR, toll-like receptor viral components, which are the main ligands of TLRs, initiating the secretion of pro-inflammatory cytokines is relevant in view of the possible microorganic etiology of RA. 34, 35) It is reasonable to expect that CS, as a common medicine and dietary supplement for arthritis, affects the TLR-induced inflammatory reactions that are thought to be involved in the pathogenesis of arthritis, but there are few reports on the effects of CSs or oligo-CSs on TLR-mediated inflammatory reactions. Although our recent paper presented results to the effect that CS-A suppressed IL-6 induced by TLR-ligands in a sizedependent manner, 36) the effects of the structure of CS were pronounced. In this study we investigated the antiinflammatory effects of CS, oligo-CS, and Di-CS on a macrophage-like cell line stimulated by a range of TLR ligands, and compared the IL-6-suppressive effects of various structures of CS and its oligosaccharides.
Materials and Methods
Materials. RPMI 1640 medium was purchased from Wako (Osaka, Japan). Penicillin-streptomycin (10,000 U/mL and 10 mg/mL in 0.9% sodium chloride respectively) were from Gibco (Gaithersburg, MD). Chondroitin sulfate A (CS-A) was from Calbiochem (Darmstadt, Germany), and chondroitin sulfate C (CS-C) was from Wako (Osaka, Japan). Chondroitinase ABC from Proteus vulgaris, fetal bovine serum (FBS), Di-CSs, and lipoteichoic acid (LTA) were from Sigma (St. Louis, MO). An Unsaturated Chondro-Disaccharide Kit (C-Kit) (chondroitin sulfate disaccharide standard for HPLC) was from Seikagaku (Tokyo), and CpG (unmethylated CpG motifs present in bacterial and viral DNA, TCC ATG ACG TTC CTG ACG TT) was from Hokkaido System Science (Sapporo, Japan). Pam3CSK4, Poly I:C, monophosphoryl lipid A (MLA), flagellin, imiquimod, and ultrapure E. coli lipopolysaccharide (LPS) were from Invivogen (San Diego, CA), and all other chemicals were of reagent grade.
Cell culture. J774.1 cells were a gift from Dr. Fumio Amano, National Institute of Infectious Diseases of Japan. They were cultured in RPMI 1640 containing 10% fetal calf serum, 40 U/mL of penicillin, and 40 mg/mL of streptomycin. The cells were incubated at 37 C in a humidified atmosphere containing 5% CO 2 and 95% air, and were serially passaged biweekly. 37) Adhering J774.1 cells were gently detached and spread on 48-well plates. They were cultured for 24 h to allow adhesion to the culture dish, and fresh medium was added before stimulation.
Enzyme-linked immunosorbent assay (ELISA). A 96-well immunoplate was coated with 50 mL of anti-mouse IL-6 capture antibody (BD Pharmingen, San Diego, CA) and incubated overnight at 4 C. After it was washed with PBS-T (PBS with 0.1% Tween 20) and blocked with 3% bovine serum albumin (BSA) in PBS-T, 50 mL of a sample solution was plated and incubated overnight at 4 C. After it was washed, 50 mL of biotinylated anti-mouse IL-6 antibody (BD Pharmingen) was added and the mixture was allowed to incubate for 1 h at room temperature. The plate was incubated with 50 mL of a streptavidin-alkaline phosphatase solution for 1 h, and then with 50 mL of a chromogenic substrate solution (4-nitrophenyl phosphate-disodium hexahydrate in diethanolamine buffer, pH 9.8). The optical density was measured at 405 nm referenced to 490 nm. Preparation of oligo-CSs. CS-A or CS-C (400 mg) dissolved in 10 mL of PBS was hydrolyzed with 0.4 U chondroitinase ABC at 37 C for 48 h. 38) After hydrolysis, the oligo-CS solutions were heated for 5 min to denature the proteins. Di-4S and Di-6S in the oligo-CS solutions were determined by strong anion-exchange high-performance liquid chromatography (SAX-HPLC). 8, 19) Statistical analysis. Results were expressed as s F-protected test for least significant difference of the mean AE SD. Differences among experimental data were assessed by one-way analysis of variance (ANOVA), and then subjected to Fisher's F-protected test for least significant difference.
Results

IL-6 secretion induced by TLR ligands in macrophage-like J774.1 cells
To determine which TLRs were functionally expressed by the J774.1 cells, cells cultured in 96-well plates were stimulated by the eight TLR ligands listed in Table 1 . The J774.1 cells proved sensitive to Pam3CSK4, LPS, and CpG ( Fig. 1) , the respective ligands of TLR1/TLR2, TLR4, and TLR9.
IL-6 secretion induced by CS-A, CS-C, and their oligosaccharides
J774.1 cells were treated with CS-A, CS-C, oligo-CS-A, oligo-CS-C, Di-4S, Di-6S, or Di-0S in the absence of TLR ligands. None of these CS-related compounds induced IL-6 secretion in the J774.1 cells (data not shown), suggesting that they do not play roles as TLR ligands.
Effects of CS-A and CS-C on IL-6 secretion induced by TLR-ligands in J774.1 cells J774.1 cells were treated with Pam3CSK4, LPS, and CpG, and the IL-6 secreted from the cells was measured after incubation with and without intact CSs for 24 h. No obvious effects of CS-A or -C on Pam3CSK4-induced IL-6 secretion were observed, although a statistic difference in IL-6 levels from the control was detected at CS concentrations of 10 and 100 mg/mL ( Fig. 2A) . LPS-induced IL-6 secretion was not affected by treatment with intact CS-A or CS-C (Fig. 2B) . On the other hand, intact CS-C markedly suppressed the CpGinduced secretion of IL-6, by 45%, at a concentration of 100 mg/mL (Fig. 2C) , whereas intact CS-A did not significantly affect IL-6 secretion.
Effects of oligo-CS-A and oligo-CS-C on IL-6 secretion induced by the TLR-ligands in J774.1 cells
Intact CS-A and CS-C were hydrolyzed with chondroitinase ABC for 48 h and the effects of these digests on IL-6 secretion were examined. No suppressive effects of oligo-CS-A and -C on Pam3CSK4-induced IL-6 secretion were clearly observed, although a statistical difference in IL-6 levels from the control was detected (Fig. 3A) . On the other hand, oligo-CS-A and oligo-CS-C caused concentrationdependent suppression of LPS-induced IL-6 secretion (Fig. 3B) . Suppression by oligo-CS-A was higher than by oligo-CS-C when the cells were treated with oligoCSs at 50 mg/mL and higher. A reduction in IL-6 secretion by 30% was observed with oligo-CS-A at 100 mg/mL, while an approximately 20% reduction of IL-6 secretion was observed with oligo-CS-C at the same concentration (Fig. 3B) . Both oligo-CS-A and oligo-CS-C markedly suppressed CpG-induced IL-6 secretion in a concentration-dependent manner (Fig. 3C ). Oligo-CS-A caused significantly higher suppression of IL-6 secretion than oligo-CS-C at concentrations of 50 mg/mL and higher. Suppression by oligo-CS-A showed a more than 70% reduction at 100 mg/mL, while oligo-CS-C showed 50% at the same concentration (Fig. 3C) . SAX-HPLC analysis of the oligo-CSs indicated that the oligo-CS-A fraction prepared in this experiment contained 30.4% Di-4S and 7.9% Di-6S, whereas the oligo-CS-C fraction contained 9.0% Di-4S and 17.3% Di-6S. Hence the effects of Di-CSs on the IL-6 secretion were examined next.
Effects of Di-CSs on IL-6 secretion induced by TLRligands in J774.1 cells
In order to determine the effects of the molecular size and structure of CS on the IL-6 secretion induced by the three TLR ligands, Di-4S (the disaccharide unit of CS-A), Di-6S (the disaccharide unit of CS-C), and Di-0S (carrying no sulfur group) were also introduced to the experiment (Fig. 4) . All three types of Di-CS suppressed Pam3CSK4-induced IL-6 secretion, but Di-4S showed the strongest IL-6 suppression among the three Di-CSs, at a concentration of 100 mg/mL (Fig. 5A) . A high 
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MLA (ng/mL) 1 10 100 LPS (ng/mL) 1 10 100 10 aa (p < 0:01) compared with the control value (0 mg/mL) for the CS-A group. bb (p < 0:01) compared with the control value (0 mg/mL) for the CS-C group. concentration (100 mg/mL) of Di-4S and Di-0S resulted in marked IL-6 suppression when J774.1 cells were stimulated with LPS. The strongest suppression was observed with Di-4S, reaching 40% (Fig. 5B) . On the other hand, Di-6S hardly suppressed LPS-induced IL-6 secretion (Fig. 5B) . CpG-induced IL-6 secretion was suppressed by all three types of Di-CS suppressed (Fig. 5C ). Di-4S showed the strongest IL-6 suppression among the three Di-CSs (Fig. 5C ), although its parent molecule, CS-A, showed rather weak activity (Fig. 2C) . The suppression caused by Di-4S was obvious at 10 mg/mL, and reached a greater than 90% reduction at 100 mg/mL (Fig. 5C ).
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Discussion
A variety of analytical methods have demonstrated that CS can be absorbed by the oral route. With the radioactive labeled technique, more than 70% of orally administered radioactivity of CS was absorbed, 11) and more than 40% of the radioactivity on partially depolymerized CS was detected in tissues 24 h after administration 9) in rats. Recently Volpi developed a form of agarose-gel electrophoresis to characterize and quantify CS absorption by the oral route. 13) Using this method, ichthyic CS plasma levels were found to increase more than 120% with a peak concentration at 8.7 h, the increase reaching significance from 4 to 16 h. 13) A thorough in vitro investigation by Barthe et al. 39) of the sites of CS degradation and absorption in the rat showed that CS degraded to Di-CSs in the contents of the colon and particularly the cecum. This suggests that in the distal gastrointestinal tract, CS is degraded to Di-CS, probably by enzymes in the intestinal flora, following higher volume transport of Di-CS.
Many studies of modulation of macrophage functions by natural substances have been reported. Activation of macrophages can be helpful to promote the body's immune system, because phagocytic macrophages kill pathogenic bacteria and also produce a variety of cytokines which activate immune cells to reinforce the immune defense functions. Activation of macrophages by milk peptides 40) and plant extracts, 41) for example, has been reported. In contrast, too much activation of macrophages, accompanied by hyperproduction of inflammatory cytokines, induces damage in cells and causes inflammatory diseases. In this case, it is important to alleviate excess activation. Many polyphenols that suppress macrophage functions have been reported. 42, 43) Arthritis is often accompanied by bacterial/viral infection, which causes macrophage activation. CS is a Di-4S, the disaccharide unit of CS-A, is sulfated on C-4 of the galactosamine, whereas Di-6S, the disaccharide unit of CS-C, is sulfated on C-6 of the galactosamine. Di-0S carries no sulfated group. useful dietary agent in recovery from arthritis. It is therefore reasonable to examine the effects of CS on the macrophages activated by bacterial/viral compounds via TLRs.
Among TLR ligands (Fig. 1) , Pam3CSK4, LPS, and CpG, the respective ligands of TLR1/TLR2, TLR4, and TLR9, were selected for further study. Among these ligands, CpG-induced IL-6 secretion was most strongly suppressed by CS, oligo-CS, and Di-CS (Figs. 2, 3 , and 5). The suppression of CpG-induced IL-6 secretion in the J774.1 cells caused by CS-C was not molecular sizedependent, but that caused by CS-A showed clear sizedependency, smaller CS-As resulting in distinctly stronger suppression (Figs. 2, 3, and 5) .
Structure-dependent IL-6 suppression by CS and its oligosaccharides was also evident in our results. Between the two intact CSs used in this study, CS-C showed significantly stronger IL-6 suppression than CS-A in CpG-stimulated cells (Fig. 2C) , but CS-A showed stronger suppression than CS-C when they were digested to oligosaccharides (Fig. 3) . This was confirmed by the finding that Di-4S, a major component of the CS-A digest, showed much stronger suppression than Di-6S, a major component of the CS-C digest (Fig. 5 ). This suggests that the sulfur group of CS plays an important role in its immune-modulating behavior, but non-sulfated Di-0S showed IL-6 suppression comparable to that of Di-6S (Fig. 5 ). This suggests that the sulfate residue is not always essential for the activity, but that the position of the sulfate residues influences it. It appears that the mechanism underlying the suppression of TLR-mediated IL-6 secretion in macrophages includes a step recognizing the different sulfation of CS and Di-CS molecules.
It is unknown how CS and its oligosaccharides differently suppress the IL-6 secretion induced by various TLR ligands. CS and its oligosaccharides might interfere with the interactions of TLR1/TLR2, TLR4, and TLR9 with their respective ligands. Our recent results suggested that Di-4S interferes with CpG-TLR9 interaction. 36) A possible suppression mechanism is that CS-A and Di-4S bind with TLR9 via its cysteine-rich domains, thereby attenuating TLR9-mediated signal transduction. Other CSs/Di-CSs are also likely to interact with TLRs via their cysteine-rich domains. 36, [44] [45] [46] [47] [48] [49] [50] [51] This interaction possibly affects the binding of TLRs with their ligands, thereby weakening the IL-6 secretion triggered by the activation of TLRs, as shown in Figs. 2, 3 , and 5.
The suppression mechanism proposed here can also explain why smaller Di-4S showed stronger Pam3CSK4-, LPS-and CpG-induced IL-6 suppression than the parent material, CS-A. Di-4S predicates a much greater number of molecules than CS-A of the same mass, thus binding much more efficiently with TLRs. It might also be possible for Di-4S to act as an antagonistic ligand of TLRs, thereby suppressing activation of the IL-6 signaling pathway. 36) TLR1/TLR2, TLR4, and TLR9 are different in terms of the structures of the ligand-binding domains. Unlike TLR1/TLR2 and TLR4, TLR9 contains an additional cysteine-rich motif that is possibly in charge of CpG binding. 36, 44, 49, 52) The presence of this additional cysteine-rich domain in the TLR9 molecule might account for the CpG-induced IL-6 secretion mediated by TLR9 is most markedly suppressed by CS-C and Di-CSs, as compared with TLR1/TLR2-and TLR4-mediated IL-6 secretion. 36) 4-Sulfated-N-acetylgalactosamine (4-SO 4 -GalNAc) is predicted to form more affinitive binding with the cysteine-rich domain of the mannose receptor than 6-SO 4 -GalNAc 46) or GalNAc. In a similar structuredependent manner, Di-4S is likely to form more affinitive binding with the cysteine-rich motif of TLRs a (p < 0:05) and aa (p < 0:01) compared with the control value (0 mg/mL) for the Di-4S group. bb (p < 0:01) compared with the control value (0 mg/mL) for the Di-6S group. c (p < 0:05) and cc (p < 0:01) compared with the control value (0 mg/mL) for the Di-0S group.
than Di-6S or Di-0S. More affinitive binding of Di-4S with the cysteine-rich motif of TLRs might enable Di-4S to exert a stronger suppressive effect on IL-6 secretion than Di-6S and Di-0S in TLR ligands, especially in CpG-stimulated J774.1 cells (Fig. 5) .
The mechanism that presented above still cannot explain why CS-C showed stronger CpG-induced IL-6 secretion than CS-A. The different conformations, defined by the sulfated position, of these two intact sulfated polysaccharides might explain this result. The sulfated group on intact CS-A is near the midline of the polysaccharide chain, while that on intact CS-C is in a peripheral position. The application of molecular modelling procedures has indicated that the sulfated group in CS-A limits the flexibility of the (1!3) linkage, that yields higher stiffness than that of CS-C in solution.
53) It is known that the position of the sulfated group of CS plays an important role in the interaction between CS and other molecules via a cysteine-rich domain. 46) The sulfated group of CS-C in a peripheral position and its more flexible conformation makes it possible for an intact CS-C molecule to serve numerous binding sites. In contrast, the midline position of sulfated groups of CS-A and its stiff confirmation render the sulfated groups difficult to expose, suggesting that only the sulfated group at the terminal end can serve as a functional binding site, unless this intact molecule is cut into oligosaccharide units to expose more sulfated groups. This hypothetical mechanism also explains, why molecular size-dependent suppression of CpGinduced IL-6 secretion can be observed in CS-A, but not in CS-C.
Conclusions
The results presented in this study suggest that, molecular size and structure are the determinants governing the immune-modulating functions of CS and its oligosaccharides, especially TLR-related inflammatory responses. Our results suggest that oligo-CSs, particularly Di-CS, are effective suppressing agents against TLR-mediated inflammation of macrophages. The immune-modulating effects of Di-CSs presented here should be helpful in understanding the antiinflammatory characteristics of CS and other sulfated polysaccharides, especially in terms of TLR-mediated inflammatory responses.
